Nemcsik János, Rodilla Enrique, Albini Fabiolucio, Doumas Michael, Boivin Jean-Marc, Gyöngyösi Helga, Kreutz Reinhold, de Pinho Rosa
Department of Family Medicine, Semmelweis University, Budapest, Hungary.
Internal Medicine Department, Hypertension and Vascular Risk Unit, Hospital Universitario de Sagunto, Sagunto, Spain.
Blood Press. 2025 Dec;34(1):2487592. doi: 10.1080/08037051.2025.2487592. Epub 2025 Apr 3.
The implementation of hypertension guidelines into the everyday practice of general practitioners (GPs) have an outmost importance to provide optimal care for patients. The aim of our study was, on the one hand to gain insight about the relationship between hypertension societies and GP societies, and on the other hand, to get feedback about the use of single pill combinations (SPC) in each country, as an indicator of guideline implementation.
The European Society of Hypertension (ESH) GP Nucleus initiated a survey containing 17 questions about the existence and number of national hypertension and GP societies, the relationship between them and with pharmacists and nurse associations, the authors of national guidelines and the availability of SPCs. The survey was sent to the national hypertension society representatives of ESH. Additionally, data about the number of SPCs sold yearly was also checked using IQVIA database.
Responses were collected from 25 European countries. In most of the countries there is only one hypertension society (23/25) and one GP society (18/25), most of which having a relationship with each other (22/25). Of the countries with national hypertension guidelines most of them are written by the national hypertension society (45%) followed by the GP society (27%) or by public administration (27%). Two thirds of the national hypertension societies (16/25) have relationship with nurse societies and half of them (12/25) with pharmacists. In 65% (15/23) of the guidelines dual SPC therapy is recommended for treatment initiation however, marked differences are present in the number of yearly sold SPCs in different countries.
National hypertension societies have remarkable impact on GPs for the management of hypertensive patients. However, improvement is needed in the collaboration with nurse and pharmacist societies and in some countries in the use of SPCs for hypertension therapy.
将高血压指南应用于全科医生（GP）的日常实践对于为患者提供最佳护理至关重要。我们研究的目的，一方面是深入了解高血压协会与全科医生协会之间的关系，另一方面是获取每个国家使用单片复方制剂（SPC）的反馈，以此作为指南实施的一个指标。
欧洲高血压学会（ESH）全科医生核心小组发起了一项调查，其中包含17个问题，涉及国家高血压协会和全科医生协会的存在情况及数量、它们之间以及与药剂师和护士协会的关系、国家指南的作者以及SPC的可获得性。该调查发送给了ESH的国家高血压协会代表。此外，还使用艾昆纬数据库检查了每年销售的SPC数量数据。
收集了来自25个欧洲国家的回复。在大多数国家，只有一个高血压协会（23/25）和一个全科医生协会（18/25），其中大多数相互之间有关系（22/25）。在有国家高血压指南的国家中，大多数指南由国家高血压协会编写（45%），其次是全科医生协会（27%）或公共管理部门（27%）。三分之二的国家高血压协会（16/25）与护士协会有关系，其中一半（12/25）与药剂师协会有关系。在65%（15/23）的指南中，推荐双SPC疗法用于起始治疗，然而，不同国家每年销售的SPC数量存在显著差异。
国家高血压协会在高血压患者管理方面对全科医生有显著影响。然而，在与护士和药剂师协会的合作以及一些国家在高血压治疗中使用SPC方面仍需改进。
